• Mashup Score: 0

    Wednesday, May 18 2022 08:50 AM – 09:15 AM ET. Breaking Down Gene Therapy and CRISPR Topics for Non-scientific Audiences Jennifer E. Adair, PhD. Fred Hutch, Seattle, WA …

    Tweet Tweets with this article
    • Fred Hutch at #ASGCT22 | Dr. Jennifer Adair presents "Breaking Down Gene Therapy and CRISPR Topics for Non-scientific Audiences" 🗓️ Wednesday, May 18, 8:50 a.m. ET | Room 206 https://t.co/D6m4tL5vJJ https://t.co/ckAoYeR8ZT

  • Mashup Score: 0

    Wednesday, May 18 2022 08:00 AM – 09:45 AM ET. Challenges and Status in Development of Gene Therapies in LMICs (Organized by the Global Outreach Committee) This symposium will highlight the barriers to the development of gene therapies in…

    Tweet Tweets with this article
    • Fred Hutch at #ASGCT22 | Dr. Jennifer Adair: Investigator Perspective on Improving Transportability of Gene Therapies in Low- and Middle-income Countries (LMICs). 🗓️ Wednesday, May 18, 8 a.m. ET | Room 102 https://t.co/Vpylo7RFyp https://t.co/uBbG7Udw3E

  • Mashup Score: 3

    Monday, May 16 2022 04:45 PM – 05:00 PM ET. Preclinical Development of Safe and Effective T Cell Receptors Specific for Mutant KRAS G12V and G12D Peptides Tijana Martinov{1}, Rachel Perret{1,2}, Shwetha Mureli{1}, Clara McCurdy{1}, Angie…

    Tweet Tweets with this article
    • Fred Hutch at #ASGCT22: Dr. Tijana Martinov (@tcellnerd) presents 103: Preclinical Development of Safe and Effective T Cell Receptors Specific for Mutant KRAS G12V and G12D Peptides. 🗓️ Monday, May 16, 4:45 p.m. ET | Room 207 https://t.co/QQy2BGdcqJ https://t.co/fnly8mHpAL

  • Mashup Score: 1

    I – Gene & Cell Therapy Trials in Progress -> Gene & Cell Therapy Trials in Progress 793: A Phase 1 Trial of Targeted DSG3-CAART Cell Therapy in Mucosal-Dominant Pemphigus Vulgaris (mPV) Patients: Early Cohort Data Type: Poster Session …

    Tweet Tweets with this article
    • $CABA "12 subjects, 3 per cohort... 9 have completed 3 months follow up." (20M, 100M, 500M) No data in abstract on 2.5B, do we see on poster 5/17? https://t.co/0uKe1QRGIg

  • Mashup Score: 3

    Registration is Now Open! Register now for the 24th Annual Meeting! Please note: ASGCT Associate Members can now register for the meeting for free! There are two ways you can register, depending on the size of your group: Individual registration: This option is meant for ASGCT Members and nonmembers. Group registration: This option is meant for five or…

    Tweet Tweets with this article
    • Attend our #ASGCT21 session today at 3:30 p.m. CT! We are partnering with @ASGCTherapy to talk about next generation #CART #celltherapy treatments. We look forward to talking to you! https://t.co/FWw7EUM7Sf https://t.co/byQ0TdeXWE

  • Mashup Score: 0

    Registration is Now Open! Register now for the 24th Annual Meeting! Please note: ASGCT Associate Members can now register for the meeting for free! There are two ways you can register, depending on the size of your group: Individual registration: This option is meant for ASGCT Members and nonmembers. Group registration: This option is meant for five or…

    Tweet Tweets with this article
    • Attend @ASGCTherapy's meeting in #genetherapy and #celltherapy, you’ll learn from more than 250 oral abstracts and more than 500 recorded abstracts. Don't forget to attend our session on Tuesday! #ASGCT21 https://t.co/FWw7EUM7Sf https://t.co/3omCNipnKZ

  • Mashup Score: 0

    Registration is Now Open! Register now for the 24th Annual Meeting! Please note: ASGCT Associate Members can now register for the meeting for free! There are two ways you can register, depending on the size of your group: Individual registration: This option is meant for ASGCT Members and nonmembers. Group registration: This option is meant for five or…

    Tweet Tweets with this article
    • During #ASGCT21, on May 11 at 3:30 p.m. (CT) we are hosting a joint session with @ASGCTherapy. Don't miss us talking about next generation #CART #celltherapy treatments. https://t.co/FWw7EUM7Sf https://t.co/BVvDH0Jp9P